Sign this petition calling on Gilead Sciences to make the #HIV drug #lenacapavir accessible for people in low- & middle-income countries. Right now it's sold in high-income countries for treatment at $42,000/yr! But generics could be made for just $40. ✍️ secure.avaaz.org/campaign/en/en…

New technologies are transforming health care, including for people living with HIV - including long-acting prevention and treatment medicines. These must be affordable and available as a global public good - now! sciencedirect.com/science/articl…

Liposomal amphotericin B (LAmB) is a lifesaving medicine for many infectious diseases, but people in low- & middle-income countries lack access to it. MSF's @jessburry, @dndi & others address the access barriers in this The Lancet Global Health article. msfaccess.org/lancet-global-…

We & CSOs call on Gavi, the Vaccine Alliance & UNICEF to ensure affordable pricing of the #mpox vaccine + support ‌Africa CDC's outbreak response coordination efforts in procuring & distributing vaccines doses - affordably, equitably & transparently. msfaccess.org/letter-csos-ca…

An HIV prevention drug that is 100% effective: this is a game-changer! Now to ensure lives over profit. Pleased to see The Lancet back UNAIDS Global' call for Gilead Sciences to make lenacapavir available rapidly & affordably to all who need in low- & middle-income countries.

Sep 2023: Danaher Corporation announces new ‘at cost’ price ($7.97) for Cepheid’ GeneXpert #TB test & commits to an annual audit of production costs👍 Now: Still no info on the audit 👎 We, Treatment Action Group (TAG) & Partners In Health urge them to ensure a transparent audit 🧵 msfaccess.org/hidden-costs-g…

In this The Lancet Global Health Viewpoint, MSF’s Elin Hoffmann Dahl & co-authors find that monoclonal antibodies (#mAbs) present the best option for preventing #Ebola infection after high-risk exposure. BUT access to mAbs for post-exposure prevention is non-existent. thelancet.com/journals/langl…

THANK YOU for the 200K+ signatures we’ve hit on our petition asking Cepheid & Danaher Corporation to drop the price of their lifesaving medical tests to $5. Cepheid & Danaher, we know you can hear us. STOP HIDING. It’s #TimeFor5

Last month we asked Gavi, the Vaccine Alliance & UNICEF to negotiate a more affordable price for the #mpox vaccine to ensure access for all. According to the vaccine's company Bavarian Nordic, the lowest market price Gavi will pay is US$65 per dose. This is inexplicably high. msfaccess.org/letter-csos-ca…

📢 Here we are! With 206,937 petition signatures from all over the world, asking you to put #PeopleOverProfits by DROPPING THE PRICE of ALL GeneXpert tests to $5 each. Danaher Corporation, Cepheid, the ball is in your court. #TimeFor5

Knock knock, Danaher! Here we are! With 206,937 petition signatures from all over the world, asking you to put #PeopleOverProfits by DROPPING THE PRICE of ALL GeneXpert tests to $5 each. Danaher Corporation, Cepheid, why won’t you listen to over 200,000 voices? #TimeFor5

Mihir, our Director of Global Health Advocacy & Policy, MSF USA, tried to deliver our petition at Danaher's HQ. Sadly they wouldn’t accept it. Danaher Corporation is ignoring the 200K+ people calling for access to lifesaving medical tests & letting down patients all over the world.

Over 206K people have spoken up, demanding Danaher Corporation & Cepheid stop profiteering off lifesaving tests for #TB, #HIV, #hepatitis & more. Today we went to deliver these petition signatures to Danaher's doorstep, but they refused to accept them. 🤷🏽‍♀️ msfaccess.org/time-5-campaig…

I wrote about 🐢🐢🐢John Green🐢🐢🐢 for The New York Times nytimes.com/2024/10/30/sci…

More than 70 TB activists from around the world called on Danaher Corporation and Cepheid at the The Union Conference to make all GeneXpert cartridges affordable for all and also to open their books and share the audit.

Scientists who discovered #insulin over 100 years ago envisioned a world where everyone could access diabetes treatment. Yet today, these corporations which ‘improve people lives worldwide’ stand in the way of millions who need life-saving medicine. Today, our message is clear.

Today on #WorldDiabetesDay, we’re at @NovoNordisk offices in Johannesburg w/ a message: 📢Resume the supply of insulin pens in South Africa AND 📢DROP THE PRICE to $1/pen so ALL people living w/ #diabetes can manage their treatment. Insulin pens shouldn’t be a luxury!

Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low testing rates in poorer countries badly hit by the virus. reut.rs/3AKfoMw reut.rs/3AKfoMw

We see the impact of #AntimicrobialResistance #AMR every day, especially in low-resource settings. With about 47 AMR programmes in 18 countries, we’re committed to addressing this critical threat for the most vulnerable people. 📄 #WAAW msfaccess.org/sites/default/…

The reported decision that the US government will end its support for Gavi, The Vaccine Alliance—set up 20 years ago to increase access to vaccines for the world's poorest countries—will have devastating consequences for children across the globe. doctorswithoutborders.org/latest/us-deci…